Finally, in distinct experimental paradigms, including the MS murine model experimental autoimmune encephalomyelitis (EAE), the systemic administration of MDP was shown to foster immune tolerance via the activation of NOD2 in myeloid cells [50,51,52,53]. This evidence concerns the gene NOD2 and myeloid sarcoma.